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Abstract
Background: Socioeconomic adversity in early life has been hypothesized to ‘‘program’’ a vulnerable phenotype with
exaggerated inflammatory responses, so increasing the risk of developing type 2 diabetes in adulthood. The aim of this
study is to test this hypothesis by assessing the extent to which the association between lifecourse socioeconomic status
and type 2 diabetes incidence is explained by chronic inflammation.
Methods and Findings: We use data from the British Whitehall II study, a prospective occupational cohort of adults
established in 1985. The inflammatory markers C-reactive protein and interleukin-6 were measured repeatedly and type 2
diabetes incidence (new cases) was monitored over an 18-year follow-up (from 1991–1993 until 2007–2009). Our analytical
sample consisted of 6,387 non-diabetic participants (1,818 women), of whom 731 (207 women) developed type 2 diabetes
over the follow-up. Cumulative exposure to low socioeconomic status from childhood to middle age was associated with an
increased risk of developing type 2 diabetes in adulthood (hazard ratio [HR] = 1.96, 95% confidence interval: 1.48–2.58 for
low cumulative lifecourse socioeconomic score and HR = 1.55, 95% confidence interval: 1.26–1.91 for low-low
socioeconomic trajectory). 25% of the excess risk associated with cumulative socioeconomic adversity across the lifecourse
and 32% of the excess risk associated with low-low socioeconomic trajectory was attributable to chronically elevated
inflammation (95% confidence intervals 16%–58%).
Conclusions: In the present study, chronic inflammation explained a substantial part of the association between lifecourse
socioeconomic disadvantage and type 2 diabetes. Further studies should be performed to confirm these findings in
population-based samples, as the Whitehall II cohort is not representative of the general population, and to examine the
extent to which social inequalities attributable to chronic inflammation are reversible.
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Introduction
A large body of evidence suggests that socioeconomically
disadvantaged groups experience an increased risk of type 2
diabetes [1,2], a metabolic disorder characterized by chronic
hyperglycemia, insulin resistance, and impaired beta-cell function
[3]. Early life factors are thought to be implicated in the
development of type 2 diabetes [4–6]. In particular, in observa-
tional studies, social adversity in childhood has been related to an
increased incidence of adult type 2 diabetes [7,8] and its risk
factors, such as the metabolic syndrome [9,10], elevated insulin
resistance [11], and raised blood glucose [12]. Type 2 diabetes is
an increasingly common chronic condition [13,14], as well as
being an important risk factor for premature mortality, cardio-
vascular disease, and depression [15–17]. A better understanding
of the mechanisms involved in the socioeconomic distribution of
type 2 diabetes is therefore essential for tackling social inequalities
in this disorder.
Traditionally, the mechanisms that have been proposed to
explain the apparent ‘‘long-reach’’ of early-life socioeconomic
circumstances on type 2 diabetes risk include mediation by
diabetes risk factors such as obesity, physical inactivity, and diet
[8,18,19]. More recently, adverse socioeconomic circumstances
have also been suggested to be associated with up-regulation of
genes affecting white blood cell count and down-regulation of
genes controlling immune cells responsiveness to glucocorticoid
signaling [20]. Evidence is also accumulating for a more
fundamental role of social and financial adversities over the entire
lifespan in programming a ‘‘vulnerable’’ phenotype that, through
glucocorticoid receptor resistance, leads to exaggerated glucocor-
ticoid levels and exacerbated inflammatory responses in adult life
[12,20–24].
The effect of social adversity on inflammation-related gene
regulation might not be limited to early life experiences, however.
An experimental study in fully grown macaques, for example,
found that changes in the social environment in mid-life affected
the expression of genes regulating the immune system, contribut-
ing to an elevated inflammatory response [25]. This finding is in
agreement with studies on humans, showing greater inflammation
in people exposed to social adversity especially in adulthood [26–
30]. In addition, low socioeconomic status (SES) across the
lifecourse has been consistently shown to predict the risk of
inflammation-related chronic conditions, such as cardiovascular
disease (CVD) and type 2 diabetes [1,2,7,11,31].
Biologically, chronic inflammation is a plausible mediator of the
association between socioeconomic adversity and type 2 diabetes.
Inflammation affects insulin signalling [32] and increases beta-cell
death [33], and markers of inflammation, such as elevated
interleukin 6 (IL-6) and C-reactive protein (CRP) levels, have
been found to be associated with future diabetes risk [34,35].
Inflammation may also increase type 2 diabetes risk indirectly via
obesity, which, as described, is a risk factor for type 2 diabetes and
is associated with increased release of inflammatory markers, such
as IL-6 [36].
Taking together the evidence linking socioeconomic adversity to
inflammation and inflammation to type 2 diabetes, it seems
reasonable to postulate that chronically increased inflammatory
activity in individuals exposed to socioeconomic adversity over the
entire lifecourse may, at least partially, mediate the association
between SES over the lifecourse and future type 2 diabetes risk. In
order to test this hypothesis, we first explore the association
between lifecourse SES and type 2 diabetes incidence, and then
examine the extent to which this association is explained, if at all,
by inflammatory markers.
Materials and Methods
Study Population and Design
Established in 1967, the focus of the original Whitehall study
was to understand the aetiology of CVD. One of the major
findings from the study was the lower rates of CVD mortality in
the highest employment grade groups [37]. This observation led to
the initiation of the Whitehall II study in 1985 to investigate a
range of possible mechanisms potentially underlying these
socioeconomic inequalities in disease, most notably psychosocial
stress. The Whitehall II study has now matured to the extent that
it comprises multiple follow-up screenings and questionnaire
surveys [38]. Thus, very unusually and of particular relevance to
the present analyses, this study has repeat measures of systemic
inflammation and type 2 diabetes incidence over the adult
lifecourse.
The Whitehall II study comprised 10,308 (3,413 women)
London-based civil servants (government employees) aged 35–
55 y at study induction [38]. The first examination (phase 1) took
place during 1985–1988, and involved a clinical examination and
a self-administered questionnaire. A 75 g oral glucose tolerance
test (OGTT) was performed for the first time at phase 3 (1991–
1993; n=8,815) and repeated at phase 5 (1997–1999), phase 7
(2003–2004), and phase 9 (2007–2009). Therefore, phase 3
examination is the ‘‘baseline’’ for the present analyses. Participants
free of type 2 diabetes at phase 3 were included and followed for
incident diabetes up to phase 9, a total of 18 y. Additional
questionnaire-only phases also assessed diabetes status at phase 4
(1995–1996), phase 6 (2001), and phase 8 (2006). The study was
approved by the University College London ethics committee, and
all participants provided written consent.
Lifecourse Socioeconomic Status
Three indicators of SES over the lifecourse were used: father’s
occupational position, the study member’s educational attainment,
and adult occupational position. These three indicators were
selected to cover the study members’ lifespan. Father’s occupa-
tional position is a common indicator of SES in childhood in the
United Kingdom [39]. Education is also a measure of SES in early
life but, being generally acquired in adolescence or young
adulthood, it can be considered as a measure of SES before
active professional life [40,41]. Finally, adult occupational position
is one of the most used indicators of adult SES [42].
Father’s occupational position was assessed retrospectively at
the baseline survey (phase 1) with the question ‘‘What is/was your
father’s main job, what kind of work does/did he do in it.’’ This
was coded based on the Registrar General’s Occupational position
classification [43] and then categorized as high (social classes I–II),
middle (social classes III NM–III M), and low (social classes IV–V).
For 310 participants, missing data on father’s occupational
position were replaced with data on father’s education, categorized
as high ($16 y of schooling), middle (14–16 y of schooling), and
low (,14 y of schooling).
Education was drawn from phase 5 of the study (1997–1999)
and it was assessed as the highest qualification attained while in
full-time education. It was grouped into three categories: high
(university degree), middle (higher secondary school), and low
(lower than higher secondary school). For non-responders at phase
5 (n=2,377), the baseline (phase 1) measure of education was used.
Adult occupational position was based on the employment
grade at phase 3 and categorized into high (administrative), middle
(professional/executive), and low (clerical/support).
At least three conceptual models describe the impact of
lifecourse socioeconomic circumstances on health in adulthood:
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(1) latent effects of early life socioeconomic circumstances on adult
health; (2) cumulative effect of exposure to adverse socioeconomic
circumstances from across the lifecourse that affect health in a
dose-response manner; and (3) pathways effects of early life
socioeconomic circumstances on individuals’ trajectories to SES in
adulthood, that in turn has an impact on health [44,45]. To
address all the conceptual models, we compare different indicators
of SES over the lifecourse for their effect on type 2 diabetes and
also assess the impact of cumulative exposure to low SES across
the lifecourse and downward lifecourse socioeconomic trajectories
on adult onset of type 2 diabetes.
A cumulative SES score was calculated using information on
father’s occupational position, participants’ education, and partic-
ipants’ occupational position at phase 3. Each SES measure was a
3-level variable with values ranging from 0 (high) to 2 (low). A
score was calculated by summing all SES measures (range 0–6).
The final cumulative SES score was further categorized as high
(score = 0–2, n=3,008), moderate (score = 3–5, n=3,212), and low
(score = 6, n= 167).
Socioeconomic trajectories from childhood to adulthood were
calculated using information on the father’s occupational position
and the study member’s occupational position. For the purposes of
deriving this variable, father’s occupational position was dichot-
omized as high (social classes I-II-III NM) and low (social classes
III M-IV-V). Occupational position of the participants was
categorized as high (administrative) or low (professional/executive
and clerical/support). Four trajectories were therefore possible:
high SES in childhood and high SES in adulthood (high-high,
n=1,805), low SES in childhood and high SES in adulthood (low-
high, n=772), high SES in childhood and low SES in adulthood
(high-low, n=2,038), and low SES in childhood and low SES in
adulthood (low-low, n=1,772).
All SES indicators were significantly correlated, with Spear-
man’s correlation coefficients ranging between 0.18 and 0.84
(Table S1).
Incident Type 2 Diabetes
At study phases 3, 5, 7, and 9, venous blood was taken after a
$5-h fast before consenting participants underwent a standard
75 g 2-h OGTT. Glucose samples were drawn into fluoride
Monovette tubes and centrifuged on site within one hour. Blood
glucose was measured using the glucose oxidase method, as
previously described [46]. At each phase, diabetes was defined by
the World Health Organization (WHO) criteria based on fasting
glucose $7.0 mmol/l or 2-h glucose $11.1 mmol/l [3]. Partic-
ipants reporting doctor diagnosed diabetes or use of diabetes
medication were classified as having diabetes regardless of their
OGTT results. The date of diabetes diagnosis was assigned
according to the interval method as the midpoint between the first
visit with a diabetes diagnosis and the last visit without diabetes
[46].
Inflammatory Markers
Fasting serum was collected between 8 am and 1 pm at phases
3, 5, and 7 and stored at270uC until analysis. CRP was measured
using a high-sensitivity immunonephelometric assay in a BN
ProSpec nephelometer (Dade Behring) [47]. IL-6 was measured
using a high-sensitivity ELISA assay (R & D Systems). Values
lower than the detection limit (0.154 mg/l for CRP and 0.08 pg/
ml for IL-6) were assigned a value equal to half the detection limit.
For CRP at phases 3, 5, and 7 there are 487 (6.4%), 287 (4.6%),
and 116 (1.9%) study members, respectively, who had their value
set at 0.077. For IL-6, there were no values below the detection
limit at any of the three phases. To examine short-term biological
variation and laboratory error, a repeated sample was taken from
a subset of 150 participants for CRP and 241 for IL-6 at phase 3
(average elapse time between samples was 32 [standard deviation
(SD) = 10.5] d), and of 533 for CRP and 329 for IL-6 at phase 7
(average elapse time was 24 [SD=11.0] d). Reliability between
samples was assessed with Pearson’s correlation coefficients:
r = 0.77 for CRP and r = 0.61 for IL-6 at phase 3 and r = 0.72
for CRP and r = 0.63 for IL-6 at phase 7 [48]. In all analyses, CRP
and IL-6 were log-transformed.
Covariates
Current smoking was self-reported at phases 1, 3, 5, and 7, and
classified as yes/no. Physical activity was assessed by using
questions on the frequency and duration of participation in
moderate or vigorous physical activity at phases 1 and 3. At phases
5 and 7, the questionnaire included 20 items on frequency and
duration of participation in different physical activities that were
used to calculate hours per week at each intensity level [49].
Participants were classified as ‘‘active’’ ($2.5 h/wk of moderate or
$1 h/wk of vigorous physical activity), ‘‘inactive’’ (#1 h/wk of
moderate and #1 h/wk of vigorous physical activity), or
‘‘moderately active’’ (if not active or inactive).
Overall diet was assessed by computing a score of adherence to
healthy dietary guidelines provided by the Alternative Healthy
Eating Index (AHEI) [50,51]. The AHEI was based on intake
levels of vegetables, fruit, nuts and soy, white-to-red meat ratio,
total fiber, trans fat, polyunsaturated-to-saturated fatty acids ratio,
long-term multivitamin use, and alcohol consumption [51]. The
score was then trichotomized based on tertiles. As the AHEI was
not available for phase 1, a diet score was computed using
information on fruit and vegetable intake and the type of bread
and milk most commonly consumed, as described previously [52].
Total carbohydrates intake (measured in grams per day and then
categorized in tertiles) was separately included in the analyses as an
additional component of diet.
Height and weight were measured directly at phases 1, 3, 5, and
7 using standard procedures. Body mass index (BMI) was then
calculated as weight in kilograms divided by height in meters
squared, and categorized in three groups (normal,25; overweight
25–29; obese $30 kg/m2) on the basis of the World Health
Organization (WHO) recommendation [53].
Classification of ethnic group was by observer; at the phase 1
screening a study team member classified participants as white
Caucasian, South Asian, Afro–Caribbean, Chinese, other or
uncertain. Ethnicity was further classified as white/non-white for
this study. Family history of type 2 diabetes (parents and siblings)
was self-reported at phases 1 and 2 and was categorized as yes/no.
Prevalent conditions considered were prevalent coronary heart
disease, prevalent stroke, prevalent cancer, and prevalent hyper-
tension (systolic/diastolic blood pressure greater or equal to140/
90 mmHg). Age at phase 3 and sex were considered as covariates
in the analyses.
Statistical Analysis
A complete case approach in proportional hazards regression
models has been shown to be problematic when data are not
missing at random [54]. To reduce this bias, we used an
imputation procedure to replace missing values on health
behaviours and inflammatory markers. Missing values on smoking,
physical activity, diet, and BMI were replaced using information
collected at the previous or the successive phases (5 to 10 y earlier
or after) (see Table S2) [52]. Missing values on inflammatory
markers were imputed using multivariate imputation based on sex,
age, ethnicity, BMI, health behaviours, and, for phases 5 and 7,
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also on inflammatory markers at the preceding phase (Table S2).
Missing values on main exposure and outcome variables
(socioeconomic indicators, diabetes status), and family history of
diabetes were not imputed. Sensitivity analyses repeated on the
non-imputed subsample yielded largely similar results (Table S3).
The association between indicators of SES across the lifecourse,
the cumulative SES score, and lifecourse SES trajectories with
health behaviours, obesity, and high levels of inflammatory
markers was assessed using logistic regressions adjusted for age,
sex, ethnicity, family history of diabetes, and prevalent conditions.
We examined the association of smoking, physical activity, diet,
BMI, and inflammatory markers assessed at phase 3 with incident
type 2 diabetes using Cox regressions with time-to-event as the
time-scale [55]. Cox regressions were also used to examine the
association between lifecourse SES and type 2 diabetes. First,
father’s occupational position, education, and adult occupational
position were entered individually into the Cox regression models.
Second, we assessed the association between our cumulative SES
score and future type 2 diabetes. As tests did not suggest departure
from a linear trend (p for departure for a linear trend $0.05), the
cumulative SES score was assessed as a continuous 3-level
variable. The hazard ratio (HR) associated with a unit change in
SES was squared to yield the HR in the lowest versus the highest
cumulative SES category. Third, we examined the association of
SES trajectories from childhood to adulthood with type 2 diabetes
incidence.
Cox regression models used to assess the SES-type 2 diabetes
incidence association were first adjusted for age, sex, ethnicity,
family history of diabetes, and prevalent conditions (model 1).
Then, smoking, physical activity, diet, BMI, and inflammatory
markers were entered first individually and then simultaneously
into model 1. The contribution of each risk factor in explaining
the SES-type 2 diabetes association was determined by the
percent attenuation in the b coefficient for SES after inclusion of
the risk factor in question to model 1: ‘‘1006(bModel 12bModel
1+risk factor(s))/(bModel 1)’’.We calculated a 95% CI around the
percentage attenuation using a bootstrap method with 1,000 re-
samplings.
In analyses of the contribution of mediating factors to the
association between SES indicators and type 2 diabetes incidence,
we entered smoking, physical activity, diet, BMI, and inflamma-
tory markers in the Cox regression models as time-dependent
covariates updated at phases 3, 5, and 7. This procedure allows for
changes in the values of the covariates over the follow-up for type
2 diabetes to be taken into account. Further, to account for long-
term exposure to these risk factors, at each follow-up period we
controlled for the risk factors at the previous phase. Thus, for the
follow-up period between phases 3 and 5, risk factors assessed at
phase 3 were entered into the model together with the risk factors
assessed at phase 1 (except for inflammatory markers that were not
measured at phase 1). For the diabetes follow-up period between
phases 5 and 7, risk factors collected at phases 3 and 5 were
entered simultaneously, and for the follow-up period between
phases 7 and 9, risk factors from phases 5 and 7 were entered
together. As our study assesses type 2 diabetes incidence, for each
follow-up period inflammatory markers are assessed premorbidly
(i.e., between 5 and 10 y before the occurrence of diabetes), thus
limiting the reciprocal confounding between type 2 diabetes and
inflammatory activity (see Figure S1). The proportional hazard
assumptions of the Cox regression models were tested using
Schoenfeld residuals and found not to be violated (all p-
values$0.05). The analyses were performed using the statistical
software STATA 12.1, StataCorp LP and SAS 9.2, SAS Institute
Inc (%BOOT and %BOOTCI macros).
Results
Of the 8,815 participants who took part in the Whitehall II
phase 3 examination, 2,429 were excluded due to one or more of
the following reasons: prevalent type 2 diabetes at phase 3
(n=162), missing follow-up on type 2 diabetes status (n=588),
serum CRP levels .10 mg/l at phase 3 or 5 (n=356) indicating
acute infection, missing data on SES indicators, such as father’s
occupational position (n=754) or education (n=696), missing data
on inflammatory markers CRP (n=721) or serum IL-6 (n=723) at
phase 3 (Table S2). Excluded participants had a somewhat lower
socioeconomic profile than included participants (27% of excluded
versus 14% of the included participants were in the lowest
occupational group, p,0.001). There were no differences in type 2
diabetes incidence between the included and excluded sample
(p=0.147) (Table S4). During the mean 14.3 y follow-up, 731
incident type 2 diabetes cases were identified: 52% on the basis of
75 g OGTT, 23% by use of diabetes medication, and 25% by
physician diagnosis.
Our analytical sample consisted of 6,387 participants (1,818
women). Table 1 shows baseline characteristics of the participants
according to indicators of SES across the lifecourse. Participants
with a low SES were older than those with a high SES (p,0.001).
The prevalence of family history of diabetes, of prevalent
conditions, and of type 2 diabetes incidence were also higher
among participants with low versus high adult occupational
position (p,0.001).
Participants in the low versus the high SES group were more
likely to be current smokers (odds ratio [OR]= 3.33, 95%
CI= 2.52, 4.39 for cumulative SES score), physically inactive
(OR=2.01, 95% CI= 1.58, 2.57 for cumulative SES score), and
have an unhealthy diet (OR=2.80, 95% CI= 2.29, 3.42 for
cumulative SES score) for all SES indicators examined (Table 2).
They also were more likely to be obese (OR=1.49, 95%
CI= 1.06, 2.09 for cumulative SES score), and have high CRP
(OR=1.61, 95% CI= 1.31, 1.98 for cumulative SES score) and Il-
6 (OR=1.39, 95% CI= 1.13, 1.71 for cumulative SES score) in
analyses additionally adjusted for unhealthy behaviors (Table 2).
As shown in Figure 1, lower lifecourse SES was associated with an
increased incidence of type 2 diabetes (Figure 1C) in a dose-
response manner. Similar socioeconomic gradients were also
observed for inflammatory markers (CRP, Figure 1A; IL-6,
Figure 1B).
Current smoking (HR=1.56, 95% CI 1.27–1.91), physical
inactivity (1.25, 95% CI 1.06–1.48), unhealthy diet (1.42, 95% CI
1.19–1.69), and higher BMI (1.61, 95% CI 1.51–1.72 per 1 SD
increase) predicted the development of type 2 diabetes over the
follow-up. Higher CRP and IL-6 concentrations were also
associated with higher incidence of type 2 diabetes. Multiple
adjustments resulted in some attenuation of these estimates but the
pattern of association persisted, apart from the association between
IL-6 and type 2 diabetes incidence, which was mostly removed
(Table 3).
Participants with a middle and low occupational position of the
father or with a middle or low personal education had an
increased risk of developing type 2 diabetes over the follow-up
compared with those whose father had a high occupational
position or whose education was high (HR=1.17, 95% CI= 1.00–
1.37 for middle versus high father’s occupational position and
HR=1.28, 95% CI=1.07–1.54 for low versus high education).
Adult occupational position was strongly associated with type 2
diabetes incidence (Table 4). Smoking, physical activity, diet, and
BMI explained 69% (95% CI 26–801) of the association between
medium father’s occupational position and type 2 diabetes, 60%
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(95% CI 28–240) of the association between low education and
type 2 diabetes, and 39% (95% CI 22–75) of the association
between low adult occupational position and type 2 diabetes.
Inflammatory markers explained 40% (95% CI 14–463) of the
association between father’s occupational position and type 2
diabetes; 36% (95% CI 17–133) of that between education and
type 2 diabetes; and 26% (95% CI 16–50) of that between
occupational position and type 2 diabetes (Table 4).
In Table 5, the association between the cumulative SES score
and type 2 diabetes incidence is presented. In analyses adjusted for
age, sex, ethnicity, family history of diabetes, and prevalent
conditions, participants with the lowest cumulative SES score (i.e.,
the most deprived) had almost double the risk (1.96; 95%
CI= 1.48–2.58) of developing diabetes during follow-up than
participants with the highest cumulative SES score. BMI
accounted for around 20% (95% CI 11–41) of this association
and all behavioral factors together for 34% (95% CI 20–68).
Inflammatory markers explained 25% (95% CI 16–48) of the
association between low cumulative SES score and type 2 diabetes
incidence, of which about 40% (i.e., 10%) was independent from
behavioral risk factors. After adjustment for all behavioral and
inflammatory risk factors, the HR for the lowest versus the highest
cumulative SES score was reduced to 1.49 (95% CI= 1.12–1.99),
a 40% (95% CI 24–78) attenuation.
Table 6 shows results for the association between lifetime SES
trajectories and type 2 diabetes incidence. Participants with low
Table 1. Study participant characteristics at baseline (Whitehall II phase 3) and type 2 diabetes incidence at a mean 14.3-y follow-
up (from phase 3 to phase 9) according to indicators of socioeconomic status in early and adult life (n= 6,387; 731 incident
diabetes cases).
Characteristics Father’s Occupational Position Education Adult Occupational Position
High Medium Low pa High Medium Low pa High Medium Low pa
n (%) 2,803
(43.9)
2,655
(41.6)
929
(14.5)
1,863
(29.2)
1,661
(26.0)
2,863
(44.8)
2,577
(40.3)
2,905
(45.5)
905
(14.2)
Age, mean (SD) 48.7
(5.9)
49.7
(6.0)
50.0
(6.1)
,0.001 47.9
(5.8)
48.6
(5.7)
50.8
(6.1)
,0.001 49.5
(5.8)
48.6
(6.1)
51.1
(6.12)
,0.001
Men, n (%) 2070
(73.9)
1,875
(70.6)
624
(67.2)
,0.001 1,491
(80.0)
1,266
(76.2)
1,812
(63.3)
,0.001 2,263
(87.9)
2,044
(70.4)
262
(28.9)
,0.001
White, n (%) 2531
(90.3)
2,496
(94.0)
885
(95.3)
,0.001 1,721
(92.4)
1,550
(93.3)
2,641
(92.3)
0.42 2,553
(99.1)
2,658
(91.5)
701
(77.5)
,0.001
Family history of type 2
diabetes, n (%)
291
(10.4)
300
(11.3)
108
(11.6)
0.35 175
(9.4)
174
(10.5)
350
(12.2)
0.007 228
(8.9)
328
(11.3)
143
(15.8)
,0.001
One or more prevalent
conditionsb, n (%)
518
(18.5)
551
(20.8)
185
(19.9)
0.11 339
(18.2)
301
(18.1)
614
(21.5)
0.002 514
(20.0)
559
(19.2)
181
(20.0)
0.78
Type 2 diabetes incidence,
n (ratec)
304
(7.6)
317
(8.8)
110
(8.6)
0.19 182
(6.9)
188
(8.1)
361
(8.6)
0.07 231
(6.0)
358
(9.0)
142
(11.5)
,0.001
ap for linear trend across socioeconomic categories.
bPrevalent conditions considered are coronary heart disease, stroke, cancer, and hypertension.
cAge, sex, and ethnicity adjusted diabetes incidence rate per 1,000 person-year over a 14.3-y mean follow-up.
CI, 95% CI.
doi:10.1371/journal.pmed.1001479.t001
Figure 1 Association of lifecourse socioeconomic status with two inflammatory markers and type 2 diabetes. Lower SES is associated
with higher CRP (A) and IL-6 levels (B) and with a greater type 2 diabetes risk (C) after adjustment for sex, age, and ethnicity. All p for linear trend
between lifecourse SES and inflammatory markers or type 2 diabetes were ,0.001. Cumulative SES score includes father’s occupational position,
participants’ education, and participants’ occupational position at phase 3. Each SES measure was a 3-level variable with values ranging from 0 (high)
to 2 (low). A score was calculated by summing each SES measure (range 0–6). The final cumulative SES score was categorized as high (score = 0–2),
middle (score = 3–5), and low (score = 6). Lifecourse SES trajectory refers to father’s occupational position and participants’ occupational position at
phase 3. p-y, person-years; T2D, type 2 diabetes.
doi:10.1371/journal.pmed.1001479.g001
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SES in childhood but high SES in adulthood were not at a higher
risk of type 2 diabetes than participants with a stable high SES
trajectory. Participants who were socially downwardly mobile
(high SES in childhood and low SES in adulthood) or had low SES
in both childhood and adulthood had, respectively, a 1.4- and a
1.6-fold increased risk of developing type 2 diabetes over the
follow-up compared to those who had high SES in both childhood
and adulthood (95% CI 1.11–1.69 for high-low trajectory and
95% CI1.26–1.91 for low-low trajectory). Inflammatory markers
explained about 30% of this increased risk (95% CI 10–60), of
which about 40% (i.e., 12% for high-low and 14% for low-low
trajectory) was independent of behavioral risk factors. The
contribution of risk factors to the association of cumulative SES
score and low-low SES trajectory from childhood to adulthood
with type 2 diabetes incidence is also illustrated in Figure 2.
The associations of indicators of SES in early life and downward
socioeconomic trajectory with type 2 diabetes incidence were
almost completely accounted for by adjustment for adult
occupational position or cumulative SES score. Adult occupational
position and cumulative SES score were independently related to
type 2 diabetes incidence (Table S5).
Sensitivity Analyses
All analyses were repeated in subgroups including participants
with complete data (Table S3); furthermore, adjustments were
extended to include factors such as pack years of cigarettes
smoked, alcohol consumption, drug intake, height, and BMI in
early adulthood (25 y of age). These sensitivity analyses yielded
similar results to those reported in the main analysis (Table S6).
Analyses were also repeated using age as the time scale instead of
time-to-event in Cox regressions; results did not vary (Table S7).
We tested whether there was a modification effect by gender or
ethnicity in the association between lifecourse SES and type 2
diabetes, and found no evidence for such an effect (p for
interaction .0.05).
We additionally assessed whether missing values at baseline
could have biased our results using multiple multivariate
imputation to replace missing values for risk factors at the study
baseline (STATA ice/micombine procedures). Analyses on the
imputed dataset (n=8,526, 909 incident type 2 diabetes cases)
were similar to those reported in the main analysis (Table S8).
Finally, in our study incident type 2 diabetes was being
predicted by inflammatory markers assessed premorbidly (5 to
10 y prior to the onset of type 2 diabetes). However, a residual
confounding of insulin resistance on inflammatory markers could
not be completely excluded as insulin resistance can be present
several years before diabetes onset [56]. We repeated all analyses
on participants with more than 10 y of follow-up (n=5,282, 440
incident diabetes cases), allowing for a gap of more than 10 y
between inflammatory markers assessment and type 2 diabetes
onset. The contribution of inflammation to the lifecourse SES-type
2 diabetes association was similar to that presented in the main
analysis (for the cumulative SES score 24% versus 27%in the main
analysis and for downward SES trajectory 25% versus 32% in
main analysis).
Discussion
Adverse socioeconomic circumstances in early and later life
have been related to an increased risk of metabolic disorders in
adulthood, but the mechanisms underlying this link remain poorly
understood. Building on recent animal models, we hypothesized
that chronic inflammation might partly explain the link between
Table 2. Odds ratios (95% CI) for the association of indicators of socioeconomic status across the lifecourse with type 2 diabetes
risk factors at baseline (Whitehall II phase 3), n= 6,387.
Type 2 Diabetes Risk Factor
Lowest vs Highest
Father’s
Occupational
Position
Lowest vs Highest
Education
Lowest vs Highest
Adult Occupation
Lowest vs Highest
Cumulative SES
Scorea
Low-Low vs High-
High SES Trajectoryb
ORc (95% CI) ORc (95% CI) ORc (95% CI) ORc (95% CI) ORc (95% CI)
Current smoking (ref.: never/former
smoking)
1.43 (1.17–1.76) 2.22 (1.84–2.69) 3.89 (3.06–4.95) 3.33 (2.52–4.39) 2.78 (2.25–3.44)
Physical inactivity (ref.: physically
active)
1.37 (1.14–1.65) 1.31 (1.12–1.54) 2.82 (2.29–3.48) 2.01 (1.58–2.57) 1.75 (1.45–2.10)
Unhealthy diet (ref.: healthy diet) 1.53 (1.32–1.77) 1.80 (1.58–2.04) 2.61 (2.19–3.10) 2.80 (2.29–3.42) 2.25 (1.95–2.60)
Highest carbohydrate intake tertile
(ref.: lower carbohydrate intake
tertiles)
0.87 (0.75–1.01) 0.79 (0.70–0.89) 0.96 (0.81–1.15) 0.80 (0.65–0.97) 0.87 (0.75–1.00)
ORd (95% CI) ORd (95% CI) ORd (95% CI) ORd (95% CI) ORd (95% CI)
BMI$30 (ref.: BMI,30) 1.30 (1.01–1.67) 1.22 (0.97–1.52) 1.47 (1.10–1.97) 1.49 (1.06–2.09) 1.31 (1.02–1.69)
Highest CRP tertile (ref.: lower CRP
tertiles)
1.36 (1.17–1.59) 1.36 (1.19–1.56) 1.36 (1.13–1.63) 1.61 (1.31–1.98) 1.26 (1.08–1.46)
Highest IL-6 tertile (ref.: lower
IL-6 tertiles)
1.41 (1.21–1.65) 1.32 (1.15–1.51) 1.33 (1.11–1.60) 1.39 (1.13–1.71) 1.33 (1.14–1.55)
aCumulative SES score includes father’s occupational position, participants’ education, and participants’ occupational position at phase 3. Each SES measure was a 3-
level variable with values ranging from 0 (high) to 2 (low). A score was calculated by summing each SES measure (range 0–6). The final cumulative SES score was
categorized as high (score = 0–2), middle (score = 3–5), and low (score = 6).
bLifecourse SES trajectory refers to father’s occupational position and participants’ occupational position at phase 3.
cModel adjusted for age, sex, ethnicity, family history of diabetes, and prevalent conditions.
dModel adjusted for age, sex, ethnicity, family history of diabetes, prevalent conditions, smoking, physical activity, diet.
b, Beta coefficient; ref., reference.
doi:10.1371/journal.pmed.1001479.t002
Socioeconomic Status, Inflammation, and Diabetes
PLOS Medicine | www.plosmedicine.org 6 July 2013 | Volume 10 | Issue 7 | e1001479
lifecourse SES and type 2 diabetes. Our findings from a large
population study confirmed this. First, we found that cumulative
exposure to low SES over the lifecourse and a downward
trajectory from high SES in childhood to low SES in adulthood
were robustly associated with an increased risk of developing type
2 diabetes over the study period. Second, inflammatory processes,
measured repeatedly through CRP and interleukin-6, contributed
to explain as much as one third of this association.
This evidence should be interpreted cautiously. As noted earlier,
early life socioeconomic circumstances can have an impact on health
in adulthood because of latent effects of early-life circumstances on
adult health, independent of socioeconomic conditions in adult life;
through cumulative effects whereby the duration of exposure to
adverse socioeconomic circumstances from across the lifecourse
affects health in a dose-response manner; or because of pathway
effects by which early life socioeconomic circumstances affect the
individuals’ trajectories to SES in later life, that in turn have an
impact on health [44]. In relation to type 2 diabetes incidence,
previous studies reported an association between duration of
exposure to socioeconomic adversity, as well as a downward
socioeconomic trajectory, and increased risk of type 2 diabetes
[45,57,58], consistently with our findings. In contrast, results for an
independent effect of childhood SES on adult incidence of type 2
diabetes have been inconsistent [8,45,57–59]. Our study does not
support the hypothesis that early-life SES would affect type 2 diabetes
in adulthood independently of SES in adult life.
In our study, participants with low lifecourse SES had increased
CRP and IL-6 concentrations compared with participants with
high lifecourse SES. These data are consistent with previous
studies reporting associations between SES and inflammatory
markers [30,60,61], including one report from the Whitehall II
cohort [62]. Our study is consistent with the hypothesis that
socioeconomic differences in inflammatory activity might explain a
considerable proportion of socioeconomic differences in inflam-
mation-related diseases, such as type 2 diabetes [32]. Importantly,
we found that only socioeconomic trajectories including low adult
SES were associated with increased type 2 diabetes risk. This
suggests that the adverse effects of low SES in early life might be
possible to reverse by favorable socioeconomic circumstances in
adulthood, a finding that is consistent with a recent animal study
[25] demonstrating that SES-related regulatory changes may also
still occur in adulthood.
Diverse biological mechanisms are likely to contribute to the
mediating role of inflammation in the lifecourse SES-type 2
diabetes association (Figure 3). First, SES could affect inflamma-
tion through stress-mediated factors involving the hypothalamic-
pituitary-adrenal axis and the autonomic nervous system [26–
28,30,63–65]. Recent evidence reporting SES-related epigenetic
changes in genomic regions regulating response to stress supports
this possibility [20–22,25]. SES differences in gene regulation of
response to stress can be reflective of environmental/dietary
exposures occurring over the lifecourse or be a direct consequence
of developmental programming in early life.
Second, lifestyle factors can underlie the associations between
inflammation, lifecourse SES, and type 2 diabetes because
inflammatory processes are related to several type 2 diabetes risk
factors. These include smoking, obesity, unhealthy diet, and
physical inactivity, all of which show strong socioeconomic
gradients [66–70]. We found that more than half of the
contribution of inflammation to SES differences in type 2 diabetes
was attributable to the pro-inflammatory effect of smoking,
physical inactivity, unhealthy diet, and obesity. In addition,
chronic stress associated with socioeconomic adversity may
influence at the same time lifestyle factors and inflammatory
activity [71].
Several other determinants of inflammation, such as subclinical
diseases (atherosclerosis and coronary heart disease) or medication
use are also socially patterned [72–74] and could account for part
of the associations between SES, inflammation, and type 2
diabetes. However, our results were adjusted for prevalent
conditions, such as coronary heart disease, stroke, cancer, and
hypertension, and additional adjustment for drug intake did not
impact our findings. Finally, further work involving assessment of
SES-related changes in gene regulation, of additional inflamma-
tory markers, and of more precise measures of adiposity will be
necessary in order to gain better understanding of the pathophys-
iological and biochemical processes linking SES, inflammation,
and type 2 diabetes.
Some limitations to this study are noteworthy. First, the
participants were from an occupational cohort, which is not
representative of the general population with regards to the
socioeconomic spectrum included and the prevalence of risk
factors observed. In particular, people who experienced
extreme social adversity in early life and eventually ended up
with temporary jobs or unemployed are not represented in this
study. Second, our measure of socioeconomic circumstances in
early-life, father’s occupational position, was collected retro-
spectively. Misclassification of father’s occupation may lead to
under- or over-estimation of its true effect on adult health
[75,76]. In the same way, our composite measures of SES rely
Table 3. Hazard ratios (95% CI) for the association of
inflammatory markers and other risk factors with type 2
diabetes incidence (n= 6,387; 731 incident diabetes cases).
Type 2 Diabetes Risk Factors HRa (95% CI) HRb (95% CI)
Smoking
Never/former smoker 1.00 (ref.) 1.00 (ref.)
Current smoker 1.56 (1.27–1.91) 1.34 (1.09–1.66)
Physical activity
Active 1.00 (ref.) 1.00 (ref.)
Moderately active 1.19 (0.98–1.45) 1.00 (0.81–1.22)
Inactive 1.25 (1.06–1.48) 1.20 (1.01–1.42)
Diet (AHEI)
Healthy 1.00 (ref.) 1.00 (ref.)
Moderately healthy 1.00 (0.83–1.20) 0.90 (0.75–1.09)
Unhealthy 1.42 (1.19–1.69) 1.24 (1.03–1.49)
Carbohydrate intake
Low 1.00 (ref.) 1.00 (ref.)
Middle 0.88 (0.74–1.06) 1.00 (0.83–1.19)
High 0.90 (0.75–1.09) 1.08 (0.89–1.30)
BMI
1 SD increase 1.61 (1.51–1.72) 1.49 (1.39–1.60)
CRP
1 SD increase 1.59 (1.46–1.73) 1.32 (1.19–1.45)
IL-6
1 SD increase 1.25 (1.16–1.34) 1.02 (0.93–1.11)
aModel adjusted for age, sex, ethnicity, family history of diabetes, and prevalent
conditions.
bModel adjusted for age, sex, ethnicity, family history of diabetes, prevalent
conditions, and mutually adjusted for all risk factors.
ref., reference.
doi:10.1371/journal.pmed.1001479.t003
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on the assumption that SES indicators are measured with the
same precision across the lifespan. The potential misclassifi-
cation issues related to father’s occupation might in part
explain the weaker impact of early life SES on type 2 diabetes
incidence.
Third, studies have suggested that the association between
SES indicators in adulthood and disease risk might in part be
explained by health-related selection into lower social classes.
A previous report using data from this cohort study, for
example, suggested that health-related selection indeed oper-
Table 5. Hazard ratios (95% CI) for the association of cumulative socioeconomic score with type 2 diabetes incidence (n= 6,387;
731 incident diabetes cases).
Models Cumulative SES Score
a
HR (95% CI) %D (95% CI)
Model 1: Adjusted for age, sex, ethnicity family history, and prevalent conditions 1.96 (1.48–2.58) ref.
Model 2: Model 1+smokingb 1.88 (1.42–2.49) 26 (215 to 21)
Model 3: Model 1+physical activityb 1.91 (1.44–2.52) 24 (212 to 21)
Model 4: Model 1+dietb 1.84 (1.39–2.44) 29 (220 to 24)
Model 5: Model 1+BMIb 1.71 (1.29–2.27) 220 (241 to 211)
Model 6: Model 1+smoking, physical activity, diet, and BMIb 1.56 (1.17–2.07) 234 (268 to 220)
Model 7: Model 1+CRPb 1.69 (1.28–2.24) 222 (241 to 213)
Model 8: Model 1+IL-6b 1.79 (1.35–2.37) 213 (227 to 28)
Model 9: Model 1+CRP +IL-6b 1.65 (1.25–2.18) 225 (248 to 216)
Model 10: Model 1+all risk factorsb 1.49 (1.12–1.99) 240 (278 to 224)
Additional contribution of CRP+IL-6 to Model 5b 210c
aThe cumulative SES score is entered as a continuous 3-level variable into the models. HR is for the lowest versus highest score.
bAll risk factors are updated at phases 3, 5, and7 and additionally adjusted for the risk factor at the previous phase.
cAdditional contribution of CRP and IL-6 to the model adjusted for age, sex, ethnicity, family history of diabetes, prevalent conditions, smoking, physical activity, BMI,
and diet.
ref., reference; D, attenuation.
doi:10.1371/journal.pmed.1001479.t005
Figure 2. Contribution of smoking, physical activity, diet, BMI, CRP, and IL-6 to the association between lifecourse socioeconomic
status and type 2 diabetes incidence. The first bar shows explanatory factors for the associations of low cumulative SES score (ref. high
cumulative SES score) (A) and adverse SES-trajectory (ref. high-high SES trajectory) (B) with type 2 diabetes (T2D). Inflammatory markers, in
combination, explain 26% (95% CI 16%–46%) of the first association (A) and 34% (95% CI 20%–62%) of the latter association (B). All associations are
adjusted for age, sex, ethnicity, family history of T2D, and prevalent conditions. Cumulative SES score includes father’s occupational position,
participants’ education, and participants’ occupational position at phase 3. Each SES measure was a 3-level variable with values ranging from 0 (high)
to 2 (low). A score was calculated by summing each SES measure (range 0–6). The final cumulative SES score was categorized as high (score = 0–2),
middle (score = 3–5), and low (score = 6). Lifecourse SES trajectory refers to father’s occupational position and participants’ occupational position at
phase 3.
doi:10.1371/journal.pmed.1001479.g002
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ates at younger ages, although it may contribute less to
socioeconomic differences in cardio-metabolic health in
midlife [77]. In the present study, reverse causation between
SES and type 2 diabetes is an unlikely explanation for the
findings as none of the participants were diabetic at the time of
the measurement of SES. However, the effect of other
morbidity on both educational attainment and occupational
position cannot be ruled out and this might in part explain the
association between declining SES trajectory and increased
risk of developing type 2 diabetes. Finally, health behaviours
were self-reported and it has been shown that questionnaire-
based measures are not entirely valid [78,79]. However, data
on smoking, diet, and physical activity were collected using
standard questions that have been validated against objectively
measured outcomes in previous studies [80–82].
This study has also important strengths. To our knowledge, it is
one of the first studies to examine the contribution of inflammation
to the association between lifecourse SES and type 2 diabetes
incidence. We assessed current and long-term exposure to raised
levels of inflammatory markers over a long follow-up; we are not
aware of other studies with such repeat measurements combined
with type 2 diabetes follow-up through OGTTs. This is important
as it allowed us to account for long-term exposure to increased
inflammatory activity in relation to objective measurement of type
2 diabetes incidence.
Our findings have several implications. First, these data provide
new evidence that inflammation might contribute to explain a
substantial part of the association between duration of exposure to
socioeconomic adversity and increased incidence of type 2
diabetes. Further studies are needed, particularly on population-
based samples, to confirm our findings. Second, our findings
extend previous results from animal models on social rank and
inflammation, and are consistent with the idea that SES might
affect regulation of inflammation-related genes. Future (epi)genetic
research is needed to test this possibility in humans. Third, this
study demonstrates the importance of using repeated measure-
ments of exposures over time to assess the contribution of long-
term inflammation to social inequalities in type 2 diabetes. Fourth,
assuming that our findings reflect a causal association, our results
suggest that tackling socioeconomic differences in inflammation,
especially among the most disadvantaged groups, might reduce
social inequalities in type 2 diabetes. However, intervention studies
will be necessary to determine the extent to which social
inequalities attributable to chronic inflammation are reversible.
Interventions known to reduce inflammation and diabetes risk
include, for example, weight management, physical activity, and
smoking cessation programs. Furthermore, anti-inflammatory
drugs are currently being studied for primary prevention of site-
specific cancers [83–85], although little evidence is available in
relation to type 2 diabetes.
Figure 3. Simplified conceptual framework for the potential role of inflammatory processes in explaining social inequalities in type
2 diabetes. Socioeconomic adversity over the lifetime is hypothesized to be associated with type 2 diabetes risk. Part of this association might be
mediated by the elevated inflammatory states resulting from altered gene expression and/or unhealthy lifestyles, both related to socioeconomic
adversity. Other factors (e.g., low birth weight) may also mediate part of the association between SES and type 2 diabetes (arrow A). Furthermore, SES
is hypothesized to contribute to elevated inflammation because of comorbid conditions (arrow B).
doi:10.1371/journal.pmed.1001479.g003
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Editors’ Summary
Background. Worldwide, more than 350 million people
have diabetes, a metabolic disorder characterized by high
amounts of glucose (sugar) in the blood. Blood sugar levels
are normally controlled by insulin, a hormone released by
the pancreas after meals (digestion of food produces
glucose). In people with type 2 diabetes (the commonest
form of diabetes) blood sugar control fails because the fat
and muscle cells that normally respond to insulin by
removing sugar from the blood become insulin resistant.
Type 2 diabetes, which was previously called adult-onset
diabetes, can be controlled with diet and exercise, and with
drugs that help the pancreas make more insulin or that make
cells more sensitive to insulin. However, as the disease
progresses, the pancreatic beta cells, which make insulin,
become impaired and patients may eventually need insulin
injections. Long-term complications, which include an
increased risk of heart disease and stroke, reduce the life
expectancy of people with diabetes by about 10 years
compared to people without diabetes.
Why Was This Study Done? Socioeconomic adversity in
childhood seems to increase the risk of developing type 2
diabetes but why? One possibility is that chronic inflamma-
tion mediates the association between socioeconomic
adversity and type 2 diabetes. Inflammation, which is the
body’s normal response to injury and disease, affects insulin
signaling and increases beta-cell death, and markers of
inflammation such as raised blood levels of C-reactive
protein and interleukin 6 are associated with future diabetes
risk. Notably, socioeconomic adversity in early life leads to
exaggerated inflammatory responses later in life and people
exposed to social adversity in adulthood show greater levels
of inflammation than people with a higher socioeconomic
status. In this prospective cohort study (an investigation that
records the baseline characteristics of a group of people and
then follows them to see who develops specific conditions),
the researchers test the hypothesis that chronically increased
inflammatory activity in individuals exposed to socioeco-
nomic adversity over their lifetime may partly mediate the
association between socioeconomic status over the life-
course and future type 2 diabetes risk.
What Did the Researchers Do and Find? To assess the
extent to which chronic inflammation explains the associa-
tion between lifecourse socioeconomic status and type 2
diabetes incidence (new cases), the researchers used data
from the Whitehall II study, a prospective occupational
cohort study initiated in 1985 to investigate the mechanisms
underlying previously observed socioeconomic inequalities
in disease. Whitehall II enrolled more than 10,000 London-
based government employees ranging from clerical/support
staff to administrative officials and monitored inflammatory
marker levels and type 2 diabetes incidence in the study
participants from 1991–1993 until 2007–2009. Of 6,387
participants who were not diabetic in 1991–1993, 731
developed diabetes during the 18-year follow-up. Compared
to participants with the highest cumulative lifecourse
socioeconomic score (calculated using information on
father’s occupational position and the participant’s educa-
tional attainment and occupational position), participants
with the lowest score had almost double the risk of
developing diabetes during follow-up. Low lifetime socio-
economic status trajectories (being socially downwardly
mobile or starting and ending with a low socioeconomic
status) were also associated with an increased risk of
developing diabetes in adulthood. A quarter of the excess
risk associated with cumulative socioeconomic adversity and
nearly a third of the excess risk associated with low
socioeconomic trajectory was attributable to chronically
increased inflammation.
What Do These Findings Mean? These findings show a
robust association between adverse socioeconomic circum-
stances over the lifecourse of the Whitehall II study
participants and the risk of type 2 diabetes and suggest
that chronic inflammation explains up to a third of this
association. The accuracy of these findings may be affected
by the measures of socioeconomic status used in the study.
Moreover, because the study participants were from an
occupational cohort, these findings need to be confirmed in
a general population. Studies are also needed to examine
the extent to which social inequalities in diabetes risk that
are attributable to chronic inflammation are reversible.
Importantly, if future studies confirm and extend the findings
reported here, it might be possible to reduce the social
inequalities in type 2 diabetes by promoting interventions
designed to reduce inflammation, including weight man-
agement, physical activity, and smoking cessation programs
and the use of anti-inflammatory drugs, among socially
disadvantaged groups.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001479.
N The US National Diabetes Information Clearinghouse
provides information about diabetes for patients, health-
care professionals, and the general public, including
information on diabetes prevention (in English and
Spanish)
N The UK National Health Service Choices website provides
information for patients and carers about type 2 diabetes;
it includes people’s stories about diabetes
N The nonprofit Diabetes UK also provides detailed informa-
tion about diabetes for patients and carers, including
information on healthy lifestyles for people with diabetes,
and has a further selection of stories from people with
diabetes; the nonprofit Healthtalkonline has interviews
with people about their experiences of diabetes
N MedlinePlus provides links to further resources and advice
about diabetes (in English and Spanish)
N Information about the Whitehall II study is available
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